Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of Volixibat for itching in patients with Primary Sclerosing Cholangitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Volixibat (volixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING